Scinai Immunotherapeutics Ltd. (SCNI)
1.18
-0.03
(-2.48%)
USD |
NASDAQ |
Oct 09, 16:00
1.195
+0.02
(+1.27%)
After-Hours: 20:00
Scinai Immunotherapeutics Gross Profit Margin (Quarterly) : -272.2% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -272.2% |
| March 31, 2026 | -228.6% |
| December 31, 2025 | 0.00% |
| September 30, 2025 | 0.00% |
| June 30, 2025 | 0.00% |
| Date | Value |
|---|---|
| March 31, 2025 | 38.90% |
| December 31, 2024 | -323.4% |
| September 30, 2024 | -444.6% |
| June 30, 2024 | -232.4% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Compugen Ltd. | -3.54% |
| Pluri, Inc. | 21.49% |
| Evogene Ltd. | -2.31% |
| CollPlant Biotechnologies Ltd. | -604.6% |
| Regentis Biomaterials Ltd. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -27.03% |
| Return on Assets | -18.31% |
| Return on Invested Capital | -20.85% |
| Profit Margin (Quarterly) | -435.4% |
| Operating Margin (Quarterly) | -466.5% |
| Return on Net Operating Assets | -22.18% |